Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney A Bednar

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Neurochemistry International|March 17, 2005
In vitro characterization of novel NR2B selective NMDA receptor antagonistsLaszlo Kiss, Gong Cheng, Bohumil Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2010
Novel CGRP receptor antagonists from central amide replacements causing a reversal of preferred chiralityMichael R Wood, Kathy M Schirripa, June J Kim, et al.
Pharmacology Research & Perspectives|March 30, 2016
Preclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonistRachel Garner, Shobha Gopalakrishnan, John A McCauley, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
Discovery of a nonpeptidic small molecule antagonist of the human platelet thrombin receptor (PAR-1)Philippe G Nantermet, James C Barrow, George F Lundell, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2009
Synthesis and evaluation of novel tricyclic benzo[4.5]cyclohepta[1.2]pyridine derivatives as NMDA/NR2B antagonistsCharles J McIntyre, John A McCauley, Bohumil Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|October 25, 2008
Potent benzimidazolone-based CGRP receptor antagonistsCory R Theberge, Rodney A Bednar, Ian M Bell, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2007
Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonistsKevin T Nguyen, Christopher F Claiborne, John A McCauley, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2009
Novel CGRP receptor antagonists through a design strategy of target simplification with addition of molecular flexibilityMichael R Wood, Kathy M Schirripa, June J Kim, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2008
Proline bis-amides as potent dual orexin receptor antagonistsJeffrey M Bergman, Anthony J Roecker, Swati P Mercer, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2013
Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs)Swati P Mercer, Anthony J Roecker, Susan Garson, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Neurochemistry International|March 17, 2005
In vitro characterization of novel NR2B selective NMDA receptor antagonistsLaszlo Kiss, Gong Cheng, Bohumil Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2010
Novel CGRP receptor antagonists from central amide replacements causing a reversal of preferred chiralityMichael R Wood, Kathy M Schirripa, June J Kim, et al.
Pharmacology Research & Perspectives|March 30, 2016
Preclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonistRachel Garner, Shobha Gopalakrishnan, John A McCauley, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
Discovery of a nonpeptidic small molecule antagonist of the human platelet thrombin receptor (PAR-1)Philippe G Nantermet, James C Barrow, George F Lundell, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2009
Synthesis and evaluation of novel tricyclic benzo[4.5]cyclohepta[1.2]pyridine derivatives as NMDA/NR2B antagonistsCharles J McIntyre, John A McCauley, Bohumil Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|October 25, 2008
Potent benzimidazolone-based CGRP receptor antagonistsCory R Theberge, Rodney A Bednar, Ian M Bell, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2007
Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonistsKevin T Nguyen, Christopher F Claiborne, John A McCauley, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2009
Novel CGRP receptor antagonists through a design strategy of target simplification with addition of molecular flexibilityMichael R Wood, Kathy M Schirripa, June J Kim, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2008
Proline bis-amides as potent dual orexin receptor antagonistsJeffrey M Bergman, Anthony J Roecker, Swati P Mercer, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2013
Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs)Swati P Mercer, Anthony J Roecker, Susan Garson, et al.
Pageof 3